O2h to Provide Discovery Support to Karyopharm Therapeutics, Inc.

CAMBRIDGE, England, June 7, 2010 – O2h (Ahmedabad, India) is pleased to announce the signing of an
agreement with Karyopharm Therapeutics, Inc. (Newton, Massachusetts, USA)
under which O2h will provide Karyopharm discovery services to advance
Karyopharm's lead small molecule program toward the nomination of a
development candidate.

Dr. Sharon Shacham, co-founder and CSO of Karyopharm, [...]

Survey Reveals Many are Ignoring Basic Measures to Check for no.1 Heart Killer Disorder in Europe

On World Heart Rhythm Week, Arrhythmia Alliance Launches 'Know Your Pulse' Campaign to Raise Awareness of the Importance of Pulse Checking to Keep Cardiac Conditions Under Control

STRATFORD-UPON-AVON, England, June 7, 2010 – Arrhythmia Alliance, the Heart Rhythm Charity, announced today the
results of a survey conducted in Europe that showed a large number of
respondents ignore [...]

Fi Asia Philippines – A New Opportunity for the Regional Food Industry

BANGKOK, June 7, 2010 – The first Food Ingredients Asia show ever held in the Philippines will
give the domestic food industry greater access to much needed ingredients and
technology from around the world. The three day business-to-business event
will also be a banquet of opportunity for international food manufacturers
who will attend from all over the world. [...]

Isobionics Introduces Natural Valencene Pure(TM)

GELEEN, The Netherlands, June 7, 2010 – Isobionics has finalized the development of a breakthrough fermentation
process for production of its natural Valencene Pure(TM). This product, which
is an aroma substance for the food, beverage, flavor and fragrance industry,
is now available on a commercial scale. Compared with conventional valencene,
which is produced from oranges, it offers the [...]

Oncolytics Biotech(R) Inc. Collaborators Present Positive Updated U.K. Phase I/II Trial Results in Advanced Solid Cancers With a Focus on the Head and Neck at the ASCO Annual Meeting

CALGARY, Canada, June 7, 2010 – Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced
today that a poster presentation covering updated results of its Phase I/II
U.K. trial (REO 011) of REOLYSIN(R) combined with paclitaxel/carboplatin for
patients with advanced cancers was presented today at the ASCO 2010 Annual
Meeting in Chicago, IL.

The poster entitled "Phase [...]

First Phase III Trial With Definitive Results in Advanced Medullary Thyroid Cancer Shows Statistically Significant Extension of Progression Free Survival for Patients

LONDON, June 7, 2010 – Results from ZETA, a phase III study in
patients with advanced medullary thyroid cancer (MTC), showed that treatment
with the investigational drug vandetanib significantly extended Progression
Free Survival (PFS), the primary endpoint of the study, by demonstrating a
54% reduction in the rate of progression compared to placebo (HR=0.46,
p=0.0001). The results of the [...]

Chiltern Achieves Supplementary Accreditation From the Medicines and Healthcare Products Regulatory Agency

LONDON, June 7, 2010 – Chiltern International Limited (Chiltern), a global contract research
organization (CRO), has announced that Chiltern Early Phase Limited, based in
Ninewells Hospital and Medical School in Dundee, Scotland, has achieved
Supplementary Accreditation from the Medicines and Healthcare products
Regulatory Agency (MHRA).

Dr Brian Sanderson, Medical Director, Chiltern Early Phase, explains, "In
November [...]

Health Robotics Announces i.v.STATION and i.v.SOFT Contract With Sandoz Canada (Novartis) and Sphynx

BOZEN, Sud-Tirol, Italy, June 7, 2010 – Health Robotics announced that its joint-venture Health Robotics Canada
Inc. (HRCI), Sandoz Canada Inc., and Sphynx Medical Inc. have all recently
signed a marketing agreement to expand into Canada the market presence of
i.v.STATION and i.v.SOFT, revolutionary technologies that provide automated
sterile compounding of intravenous medications and parenteral nutrition to
hospitals.

[...]

Vertellus Specialties Moves Forward With 3-Cyanopyridine and Vitamin B3 Production Expansion in Asia

INDIANAPOLIS, June 7, 2010 – Vertellus Specialties Inc. ("Vertellus" or the "Company") announced today
that it will break ground on a new 3-cyanopyridine production unit at
Vertellus' production facility in Nantong, Jiangsu, China. This unit is a
continuation of a larger effort to expand production capacity in Nantong. It
will increase Vertellus' Vitamin B3 manufacturing capacity in the [...]

Study Reveals Survival Benefit for Patients With Inoperable Hepatocellular Carcinoma (HCC) Treated With a Unique Combination of Radioactive Microspheres and Standard-of-Care Systemic Therapy

CHICAGO, June 7, 2010 – A unique combination of liver targeted radioactive microspheres
(SIR-Spheres) and a standard-of-care systemic agent (Sorafenib) appears to
confer a survival benefit for patients with inoperable primary hepatocellular
cancer (HCC) including those with disease that has spread outside the liver,
according to the results of a prospective clinical study presented today at
the 46th American [...]

Elsevier and InfoDesk Collaborate to Co-develop Federated Drug Pipeline Intelligence Solution

First Release to Integrate Comprehensive Drug Pipeline Data and Real-Time Intelligence From Multiple Content Sources in a Single Search

NEW YORK, June 7, 2010 – Elsevier, a world-leading healthcare and scientific publisher, announced
today that it has reached an agreement with Tarrytown, New York based
InfoDesk to co-develop a federated drug pipeline intelligence solution for
pharmaceutical and life [...]

Commercial Insight: Osteoporosis – Market Players Maximize Revenue Growth Before the Next Challenging Phase Report now Available on ReportsandReports

DALLAS, Texas, June 7, 2010 – ReportsandReports Announce it Will Carry the Commercial Insight
Osteoporosis Market Players Maximize Revenue Growth Before the Next
Challenging Phase Market Research Report (
www.reportsandreports.com/Report/24113/) in its Store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/commercial-insight-osteoporos
is-market-players-maximize-revenu/
(Due to the length of these URLs, it may be necessary to copy [...]

Clinical Diagnostics in India: Market Analyses and Participant Directory Report Now Available on ReportsandReports

DALLAS, June 7, 2010 – ReportsandReports Announces it Will Carry the Clinical Diagnostics in
India: Market Analyses and Participant Directory Market (
www.reportsandreports.com/Report/25249/) Research Report in its Store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/clinical-diagnostics-in-india
-market-analyses-and-participant-di/
(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into [...]

Pieris AG Appoints Chief Scientific Officer

FREISING-WEIHENSTEPHAN, Germany, June 7, 2010 – Pieris AG announced today that Laurent Audoly, Ph.D., has joined the
company as Chief Scientific Officer, effective immediately. Dr. Audoly, most
recently Biologics Research Site Lead at Merck & Co. Inc., brings both pharma
and biotech experience, with extensive expertise in therapeutic protein drug
development.

"Laurent has an impressive [...]

Landmark Study Confirms GRAZAX(R) as the Only Grass Allergy Immunotherapy Tablet to Show Sustained Effect 2 Years After Treatment Completion

LONDON, June 7, 2010 – Data published at the European Allergy, Asthma & Clinical
Immunology (EAACI) congress in London today documents that GRAZAX(R) is the
only allergy immunotherapy tablet (AIT) to show sustained disease control 2
years after treatment completion. Leading specialists emphasise the relevance
of the data with regard to inclusion in guidelines for treatment of grass
pollen [...]

Melinda Gates Calls for Global Action to Save Women’s and Children’s Lives

Gates Foundation Commits US$1.5 Billion for Integrated Women's and Children's Health Programs

WASHINGTON, June 7, 2010 – Melinda Gates today urged global leaders to make women's and children's
health a top priority, and announced that the Gates Foundation will invest
US$1.5 billion over the next five years to support maternal and child health,
family planning, and nutrition programs [...]

Confused Britons Believe Injections are Main Option for Managing Type 2 Diabetes

New Tablet for Type 2 Diabetes Launched Today
LONDON, June 8, 2010 – When Britons think about type 2 diabetes, one of their greatest concerns
is potentially needing to inject themselves,1 as estimated by a new survey
released today. Despite tablets being available to help manage the condition,
nearly half (46 percent) of those surveyed still wrongly perceive [...]

Personal Health Records App Debuts on iPad

DETROIT, June 8, 2010 – Webahn, Inc. today announced that Capzule PHR, the first personal health
records App for iPad, is now available on the App Store. Capzule PHR is a
universal app that lets iPhone and iPod touch users install it as well.

Capzule PHR is also the first PHR on iPhone [...]